BSX
Boston Scientific Corp
43.70$
+0.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.2% | 8.0% | 11.6% | 15.8% | 3.2% | 17.1% | 15.2% | 15.7% | 12.0% | 17.6% | 20.5% | 22.6% | |
| 9.8% | 10.3% | 9.7% | 9.3% | 9.1% | 9.4% | 11.3% | 9.2% | 9.0% | 8.4% | 7.6% | 6.8% | |
| 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.5% | 1.7% | 1.6% | 1.7% | 1.6% | 1.6% | 1.5% | |
| 3.9% | 2.4% | 1.5% | 2.8% | 0.0% | 2.9% | 2.1% | 0.8% | 3.2% | – | – | – | |
| 13.0% | 3.7% | 0.0% | 0.7% | -22.0% | -2.6% | 0.4% | -3.0% | -7.9% | -5.4% | -2.8% | -1.2% | |
| 3.5% | 3.3% | 4.5% | 3.5% | 3.2% | 4.3% | 3.8% | 4.7% | 4.8% | 5.6% | 4.7% | 4.4% | |
| -10.1% | -29.2% | -10.6% | -11.2% | -19.6% | -47.0% | -4.1% | -13.4% | -15.9% | -18.1% | -34.0% | -13.2% | |
| 10.3% | 0.0% | 0.0% | 0.3% | 0.3% | 0.3% | 0.3% | 0.5% | 0.4% | 0.2% | 0.0% | – | |
| -1.7% | 1.5% | 1.3% | 0.9% | 1.0% | 1.1% | -5.4% | 0.9% | 1.1% | 1.3% | 1.4% | 1.4% | |
| 18.8% | 19.1% | -2.3% | 1.4% | 14.3% | 26.0% | -10.1% | -1.4% | -1.3% | 0.0% | 10.9% | -2.4% | |
| -2.0% | 17.7% | -2.5% | 1.2% | 14.6% | 27.7% | 3.0% | -0.8% | -4.3% | 0.0% | 10.8% | -2.0% | |
| 5.0% | -3.6% | -1.5% | 5.9% | -1.9% | -2.1% | 14.0% | 1.5% | -8.2% | -0.6% | -2.7% | 7.7% | |
| 13.7% | 4.7% | 7.1% | 12.2% | -0.1% | 12.8% | 11.4% | 11.1% | 7.2% | 12.0% | 15.8% | 18.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.